Beers, STOPP/START, and PRISCUS: A critical analysis of their evolution and applicability in geriatrics prescribing.

dc.contributor.authorAlemán Fernández, Eliezer
dc.contributor.authorSiverio Mota, Dany
dc.contributor.authorVicet Muro, Liliana
dc.contributor.authorDelgado-Hernández, René
dc.contributor.authorMachado-Rivero, Manuel Osvaldo
dc.date.accessioned2026-01-13T09:45:47Z
dc.date.available2026-01-13T09:45:47Z
dc.date.issued2025-03-18
dc.date.updated2026-01-13T09:45:47Z
dc.description.abstractIntroduction: Polypharmacy, defined as the concomitant use of five or more medications, is common in older adults. Potentially inappropriate medications (PIMs) are drugs whose risks outweigh their potential benefits in older adults, especially when other effective alternatives are available. The objective of this research is to conduct a comparative analysis of the evolution, cross-cultural adaptations, advantages, and limitations of the Beers, STOPP/START, and PRISCUS criteria to evaluate their applicability in diverse clinical contexts.Method: A critical narrative review of articles retrieved from the PubMed, LILACS, SciELO, and Cochrane databases. The search was limited to the period between 2014 and 2024, with no initial language restrictions applied. Original articles, systematic reviews, clinical practice guidelines, and validation studies were included.Results: Out of the 675 references retrieved, 31 articles were selected after applying the inclusion and exclusion criteria. The Beers criteria accounted for 73.7 % of the total identified publications (n=498/675), and the 11 adaptations of the STOPP/START criteria were noteworthy.Conclusions: The Beers and STOPP/START criteria have transcended their original purpose to become foundational pillars for the development of local tools. Their value lies not only in their direct application but also in their role as reference frameworks for the creation and validation of culturally adapted criteria.
dc.format.extent13 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec763568
dc.identifier.issn0004-2927
dc.identifier.urihttps://hdl.handle.net/2445/225355
dc.language.isospa
dc.publisherUniversidad de Granada
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.30827/ars.v67i1.34825
dc.relation.ispartofArs Pharmaceutica, 2025, vol. 67, num.1, p. 113-125
dc.relation.urihttps://doi.org/10.30827/ars.v67i1.34825
dc.rightscc-by-nc-nd (c) Alemán-Fernández E et al., 2025
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.classificationInteraccions dels medicaments
dc.subject.classificationFarmacologia geriàtrica
dc.subject.classificationTerapèutica
dc.subject.otherDrug interactions
dc.subject.otherGeriatric pharmacology
dc.subject.otherTherapeutics
dc.titleBeers, STOPP/START, and PRISCUS: A critical analysis of their evolution and applicability in geriatrics prescribing.
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
910814.pdf
Mida:
299.79 KB
Format:
Adobe Portable Document Format